Institutional Investors Increase Holdings in Johnson & Johnson
1 report, 1 independent
Updated Oct 15
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Johnson & Johnson filed recent stock holdings with the SEC on October 15, 2026. According to reports, several institutional investors increased their stakes in the company during the third quarter. For instance, Mather Group LLC grew its holdings by 21.3%, while West Wealth Group LLC raised its holdings by 837.5%.
From tickerreport.com
Why it matters
The filings detail substantial purchases by large investors, indicating increased confidence in Johnson & Johnson's financial outlook. These reports provide insight into institutional demand for the company's stock.
From tickerreport.com
Who's involved
- Johnson & JohnsonThe company whose stock holdings were reported by various investors
- SECThe regulatory body receiving the mandatory financial disclosures
Keep exploring
The entities involved
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
SEC
Slovak company
Related events
- Institutional investors boosted their stake in Johnson & Johnson (JNJ) shares, highlighting the company's drug profits and balance sheet in filings with the SEC.
- SEC filing relates to stock traded on Nasdaq.
- Shell disclosed its holdings to the SEC on September 8, 2026.
- Goldman Sachs CEO David M. Solomon sold shares and filed the transaction with the SEC.
- Insider transactions were disclosed in an SEC filing, showing a hedge fund bought a new stake in Strategy Inc stock.